Abstract
MicroRNAs are noncoding RNAs that inhibit the expression of their targets in a sequence-specific manner and play crucial roles during oncogenesis. Here we show that microRNA-7 (miR-7) inhibits p21-activated kinase 1 (Pak1) expression, a widely up-regulated signaling kinase in multiple human cancers, by targeting the 3'-untranslated region (UTR) of Pak1 mRNA. We noticed an inverse correlation between the levels of endogenous miR-7 and Pak1 expression in human cancer cells. We discovered that endogenous miR-7 expression is positively regulated by a homeodomain transcription factor, HoxD10, the loss of which leads to an increased invasiveness. HoxD10 directly interacts with the miR-7 chromatin. Accordingly, the levels of Pak1 protein are progressively up-regulated whereas those of miR-7 and its upstream activator HoxD10 are progressively down-regulated in a cellular model of breast cancer progression from low to highly invasive phenotypes. Furthermore, HoxD10 expression in highly invasive breast cancer cells resulted in an increased miR-7 expression but reduced Pak1 3'-UTR-luciferase activity and reduced Pak1 protein. Finally, we show that miR-7 introduction inhibits the motility, invasiveness, anchorage-independent growth, and tumorigenic potential of highly invasive breast cancer cells. Collectively, these findings establish for the first time that Pak1 is a target of miR-7 and that HoxD10 plays a regulatory role in modifying the expression of miR-7 and, consequently, the functions of the miR-7-Pak1 pathway in human cancer cells.
MeSH Terms
3' Untranslated Regions/physiology
Adaptor Proteins, Signal Transducing/analysis
Breast Neoplasms/pathology
Cell Line, Tumor
Cell Movement
ErbB Receptors/analysis
Female
Gene Expression Regulation
Homeodomain Proteins/physiology
Humans
Insulin Receptor Substrate Proteins
MicroRNAs/genetics,physiology
Neoplasm Invasiveness
Promoter Regions, Genetic
Transcription Factors/physiology
p21-Activated Kinases/analysis,antagonists & inhibitors,genetics,physiology
Chemicals
3' Untranslated Regions
Adaptor Proteins, Signal Transducing
Homeodomain Proteins
IRS1 protein, human
Insulin Receptor Substrate Proteins
MicroRNAs
Transcription Factors
HOXD10 protein, human
ErbB Receptors
PAK1 protein, human
p21-Activated Kinases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Reddy Sirigiri Divijendra Natha
Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.
Ohshiro Kazufumi
Rayala Suresh K
Kumar Rakesh
References (20)
20 references, click to expand
-
Nontransgenic models of breast cancer.
Breast Cancer Res. 2000;2(5):331-4
PMID: 11250725
-
microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.
Cancer Res. 2008 May 15;68(10):3566-72
PMID: 18483236
-
Biology of the p21-activated kinases.
Annu Rev Biochem. 2003;72:743-81
PMID: 12676796
-
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
PMID: 14973191
-
Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes.
Cancer Cell. 2004 Jun;5(6):575-85
PMID: 15193260
-
Perspective: machines for RNAi.
Genes Dev. 2005 Mar 1;19(5):517-29
PMID: 15741316
-
A microRNA polycistron as a potential human oncogene.
Nature. 2005 Jun 9;435(7043):828-33
PMID: 15944707
-
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 2005 Aug 15;65(16):7065-70
PMID: 16103053
-
Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model.
Cancer Res. 2005 Aug 15;65(16):7177-85
PMID: 16103068
-
A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the Drosophila eye.
Cell. 2005 Dec 29;123(7):1267-77
PMID: 16377567
-
miRBase: microRNA sequences, targets and gene nomenclature.
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4
PMID: 16381832
-
MicroRNAs as therapeutic targets.
N Engl J Med. 2006 Mar 16;354(11):1194-5
PMID: 16540623
-
Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
J Natl Cancer Inst. 2006 May 17;98(10):671-80
PMID: 16705121
-
p21-activated kinases in cancer.
Nat Rev Cancer. 2006 Jun;6(6):459-71
PMID: 16723992
-
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
Nature. 2007 Oct 11;449(7163):682-8
PMID: 17898713
-
2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase.
Mol Pharmacol. 2007 Nov;72(5):1124-31
PMID: 17673571
-
Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma.
Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6603-9
PMID: 18006760
-
Multilevel regulation of gene expression by microRNAs.
Science. 2008 Mar 28;319(5871):1789-90
PMID: 18369137
-
An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase.
Chem Biol. 2008 Apr;15(4):322-31
PMID: 18420139
-
Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation.
Nat Genet. 2002 Apr;30(4):363-4
PMID: 11896390